AtheroNova, Inc.
(Other OTC/NBB : AHRO)

( )
AHRO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Miscellaneous » Miscellaneous
symbolcompany%chnglast%shortavg$volume
PRPLPurple Innovation, Inc.
0.00%8.150.0%$3.29m
FLNTFluent, Inc.
4.46%2.110.0%$1.07m
ABILAbility, Inc.
2.06%0.591.8%$0.41m
LMBLimbach Holdings, Inc.
0.73%2.750.8%$0.34m
XELAExela Technologies, Inc.
-1.72%0.290.0%$0.28m
NEXTNextDecade Corp.
-3.28%6.190.0%$0.22m
SGLBSigma Labs, Inc.
2.94%1.050.2%$0.21m
SHIPSeanergy Maritime Holdings Corp.
-1.66%0.517.5%$0.14m
INSEInspired Entertainment, Inc.
-2.12%6.930.5%$0.07m
ROSERosehill Resources, Inc.
0.93%1.090.0%$0.07m
PMEPingtan Marine Enterprise, Ltd.
-4.94%1.300.9%$0.02m
TMSRTMSR Holding Co., Ltd.
-0.97%0.980.0%$0.01m
SGOCSGOCO Group Ltd.
6.38%1.000.0%$0.00m

Company Profile

AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA.